Rhumbline Advisers Sells 16,320 Shares of HCA Healthcare, Inc. $HCA

Rhumbline Advisers decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 298,910 shares of the company’s stock after selling 16,320 shares during the quarter. Rhumbline Advisers owned about 0.13% of HCA Healthcare worth $127,395,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in HCA. Clearstead Trust LLC lifted its holdings in HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after acquiring an additional 53 shares in the last quarter. Harbor Capital Advisors Inc. grew its position in shares of HCA Healthcare by 82.9% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after purchasing an additional 34 shares during the period. Twin Peaks Wealth Advisors LLC acquired a new stake in HCA Healthcare during the 2nd quarter worth approximately $40,000. Compound Global Advisors LLC acquired a new position in shares of HCA Healthcare in the third quarter valued at approximately $44,000. Finally, True Wealth Design LLC lifted its position in HCA Healthcare by 179.5% in the 3rd quarter. True Wealth Design LLC now owns 109 shares of the company’s stock valued at $47,000 after acquiring an additional 70 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 1,500 shares of the company’s stock in a transaction on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the sale, the executive vice president directly owned 30,003 shares in the company, valued at $14,944,194.27. This represents a 4.76% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $530.95 on Thursday. The company has a 50-day simple moving average of $480.78 and a 200 day simple moving average of $446.23. The company has a market capitalization of $121.16 billion, a price-to-earnings ratio of 18.71, a PEG ratio of 1.54 and a beta of 1.36. HCA Healthcare, Inc. has a 52 week low of $295.00 and a 52 week high of $534.59.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The company had revenue of $19.51 billion for the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter last year, the business earned $6.22 earnings per share. HCA Healthcare’s revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be paid a dividend of $0.78 per share. The ex-dividend date is Tuesday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is currently 10.15%.

Analyst Ratings Changes

A number of analysts have recently commented on HCA shares. Royal Bank Of Canada boosted their price target on HCA Healthcare from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Wednesday, January 28th. Barclays raised their price target on shares of HCA Healthcare from $494.00 to $551.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 28th. Cantor Fitzgerald increased their target price on shares of HCA Healthcare from $525.00 to $588.00 and gave the stock an “overweight” rating in a report on Wednesday, January 28th. Jefferies Financial Group boosted their price target on shares of HCA Healthcare from $535.00 to $590.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Finally, KeyCorp set a $503.00 target price on HCA Healthcare in a research report on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $523.27.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Zacks Research raised several forward estimates for HCA, most notably lifting FY2026 EPS to $29.31 (from $28.47) and boosting FY2027 to $33.44 and FY2028 to $37.67 — moves that imply stronger earnings power versus prior forecasts and support an upgraded long‑range outlook. Zacks retains a “Hold” rating, but the raised numbers likely underpin investor optimism.
• Neutral Sentiment: Zacks also adjusted near‑term quarter forecasts unevenly — raising multiple 2026/2027 quarter estimates (Q2–Q4 2026, Q1–Q4 2027, Q3–Q4 2027) while trimming Q1 2026 slightly to $6.93 from $7.04. This is a modest timing shift rather than a material downgrade to the multi‑year view.
• Neutral Sentiment: Local expansion: HCA’s StoneSprings Hospital Center is pursuing conversion of a Chantilly deli into a freestanding ER — a small footprint growth move that could boost local volumes and capture urgent‑care/ER demand in that market over time. HCA’s StoneSprings Hospital Center looks to turn Chantilly deli into freestanding ER
• Neutral Sentiment: Asset monetization: A buyer completed a sale of HCA ASC real estate — potentially a financing/portfolio optimization move that can free capital or improve balance‑sheet flexibility, though transaction specifics and cash impact were not detailed. HCA ASC real estate sold
• Neutral Sentiment: Executive moves: A former HCA Florida executive has taken a COO role at Memorial Health (Georgia), and HCA veteran leadership was referenced in Memorial’s hire — routine senior‑management mobility that may have limited operational impact on HCA overall. Former HCA Florida executive joins Memorial Health as COO HCA veteran named COO of Memorial Health in Georgia
• Neutral Sentiment: Regional services/transport: AmeriPro Health expanded Florida interfacility transport operations — industry activity that can influence patient flow logistics around hospitals, but no direct HCA relationship was specified. AmeriPro Health expands Fla. operations with new interfacility transport partnership

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.